Market News

HK News

20 stories
globenewswire

Li Auto Inc. June 2026 Delivery Update

BEIJING, China, July 01, 2026 (GLOBE NEWSWIRE) -- Li Auto Inc. (“Li Auto” or the “Company”) NASDAQ:LI; HKEX:2015, a leader in China’s new energy vehicle market, today announced that it delivered 30,895 vehicles in June 2026. As of June 30, 2026, Li Auto’s cumulative deliveries reached 1,733,687.As…

GlobeNewswire en
Stocks HK
globenewswire

Mint Signed MoU with Ascendze Pte. Ltd. to Advance Strategic Expansion in Singapore’s Semiconductor and Robotics Sector

Hong Kong, June 30, 2026 (GLOBE NEWSWIRE) -- Mint Incorporation Limited (“Mint” or the “Company”, together with its subsidiaries, the “Group”, NASDAQ:MIMI, a Hong Kong-based company strategically focused on artificial intelligence (AI) and robotics, and an established business interior design and…

GlobeNewswire en
Stocks HKSG
globenewswire

Creative Global Technology Holdings Limited Receives Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

HONG KONG, June 29, 2026 (GLOBE NEWSWIRE) -- Creative Global Technology Holdings Limited (“CGTL”, the “Company”, or “we”) NASDAQ:CGTL, a Hong Kong-based company sourcing and reselling recycled consumer electronic devices, today announced that, onJune 26, 2026, the Company received a notification le…

GlobeNewswire en
Stocks HK

Futu vs. Upstart: Which Fintech Stock Fits Your Portfolio Best?

Futu Holdings FUTU and Upstart Holdings UPST both sit in the fintech world, but they give investors exposure to very different stories. Futu is a digital brokerage and wealth management platform with a strong base in Hong Kong and growing international markets. Its business benefits when investors…

Zacks en
Stocks HK
NEWS prnewswire

Alebund Pharmaceuticals (09637.HK) Debuts on the HKEx Main Board

Deepening Its Commitment to Kidney Disease and Accelerating Toward Becoming a Global Leader in Renal InnovationSHANGHAI, June 29, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; stock code: 09637.HK), a biopharmaceutical company focused on kidney disease…

PR Newswire en
ETFsStocks HK